Learn More About CMT Research
Find a CMTA Center of Excellence
Get Involved with our Youth Program
Participate in a CMTA Event

CMTA News

CMTA-INC Alliance Announces 2025 Inherited Neuropathies Fellowship Recipient

Read More

CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery

CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery

Read More

CMTA Announces New Center of Excellence in Cincinnati

CMTA Announces New Center of Excellence in Cincinnati

Read More

CMT2F Study Achieves Full Enrollment - Extra Participants Needed

CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants

Read More

MRI Shows Promise as a Biomarker for CMT1A Progression

Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE

Read More

CMTA Announces New Center of Excellence in Canada

Read More

CMTA-INC Alliance Announces 2025 Inherited Neuropathies Fellowship Recipient

CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery

CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants

Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE

CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B

Accelerating Genetic Therapy for CMT4B1: A CMTA Research Update

Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT)

CMTA’s $300K Investment in CRISPR for CMT2A

Accelerating Research. Empowering Patients.

CMT The Greeves Family

Accelerating Research

Nearly $30 million invested in CMTA-STAR to support research projects for all CMT types.

Our Research

Empowering Patients

CMTA actively works to improve the quality of life for all CMT-affected families.

Living with CMT